
Renaissancere (RNR) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
3.2B
Net Income
1.2B
36.52%
EPS (Diluted)
$17.20
Balance Sheet Metrics
Total Assets
53.6B
Total Liabilities
36.6B
Shareholders Equity
17.0B
Debt to Equity
2.15
Cash Flow Metrics
Operating Cash Flow
-1.8B
Free Cash Flow
157.8M
Revenue & Profitability Trend
Renaissancere Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 11.6B | 9.1B | 5.0B | 5.3B | 5.2B |
Cost of Goods Sold | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
Gross Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | - | - | 323.5M | 253.3M | 303.7M |
Other Operating Expenses | 631.4M | 502.8M | 323.5M | 253.3M | 303.7M |
Total Operating Expenses | 631.4M | 502.8M | 646.9M | 506.7M | 607.3M |
Operating Income | - | - | - | - | - |
Operating Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Non-Operating Items | |||||
Interest Income | - | - | - | - | - |
Interest Expense | 93.8M | 73.2M | 48.3M | 47.5M | 50.5M |
Other Non-Operating Income | 1.9M | -6.2M | 12.6M | 10.9M | 213.0K |
Pre-tax Income | 3.0B | 3.1B | -1.2B | -114.1M | 995.9M |
Income Tax | 32.6M | -510.1M | -59.0M | -10.7M | 2.9M |
Effective Tax Rate % | 1.1% | -16.4% | 0.0% | 0.0% | 0.3% |
Net Income | 3.0B | 3.6B | -1.2B | -103.4M | 993.1M |
Net Margin % | 25.4% | 39.8% | -23.0% | -2.0% | 19.3% |
Key Metrics | |||||
EBITDA | - | - | - | - | - |
EPS (Basic) | $35.31 | $52.40 | $-25.50 | $-1.57 | $15.34 |
EPS (Diluted) | $35.21 | $52.27 | $-25.50 | $-1.57 | $15.31 |
Basic Shares Outstanding | 51186000 | 47493000 | 43040000 | 47171000 | 47103000 |
Diluted Shares Outstanding | 51186000 | 47493000 | 43040000 | 47171000 | 47103000 |
Income Statement Trend
Renaissancere Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 1.7B | 1.9B | 1.2B | 1.9B | 1.7B |
Short-term Investments | 4.5B | 4.6B | 4.7B | 5.3B | 5.0B |
Accounts Receivable | 11.8B | 12.6B | 9.9B | 8.1B | 5.8B |
Inventory | - | - | - | - | - |
Other Current Assets | - | - | - | - | - |
Total Current Assets | - | - | - | - | - |
Non-Current Assets | |||||
Property, Plant & Equipment | - | - | - | - | - |
Goodwill | 1.0B | 1.1B | 448.7M | 449.8M | 456.1M |
Intangible Assets | 403.6M | 474.8M | 26.9M | 37.2M | 43.2M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | - | - | - | - | - |
Total Non-Current Assets | - | - | - | - | - |
Total Assets | 50.7B | - | - | - | - |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 2.8B | 3.2B | 3.9B | 3.9B | 3.5B |
Short-term Debt | - | 75.0M | 30.0M | 30.0M | - |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | - | - | - | - | - |
Total Current Liabilities | - | - | - | - | - |
Non-Current Liabilities | |||||
Long-term Debt | 1.9B | 1.9B | 1.1B | 1.1B | 1.1B |
Deferred Tax Liabilities | - | - | - | - | - |
Other Non-Current Liabilities | - | - | - | - | - |
Total Non-Current Liabilities | - | - | - | - | - |
Total Liabilities | 33.2B | - | - | - | - |
Equity | |||||
Common Stock | 50.2M | 52.7M | 43.7M | 44.4M | 50.8M |
Retained Earnings | 8.3B | 6.5B | 4.1B | 5.2B | 5.4B |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 17.6B | 15.6B | 9.9B | 10.2B | 10.9B |
Key Metrics | |||||
Total Debt | 1.9B | 2.0B | 1.2B | 1.2B | 1.1B |
Working Capital | 0 | 0 | 0 | 0 | 0 |
Balance Sheet Composition
Renaissancere Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 3.0B | 3.6B | -1.2B | -103.4M | 993.1M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | 99.8M | -1.1B | -2.0B | -2.3B | 408.7M |
Operating Cash Flow | 3.1B | 2.5B | -3.2B | -2.4B | 1.4B |
Investing Activities | |||||
Capital Expenditures | - | - | - | - | - |
Acquisitions | -16.0M | -1.9B | -200.8M | 191.1M | 143.1M |
Investment Purchases | -59.4B | -25.6B | -25.5B | -16.6B | -17.6B |
Investment Sales | 56.4B | 23.6B | 22.7B | 15.5B | 15.2B |
Investing Cash Flow | -3.1B | -3.8B | -3.0B | -816.3M | -2.3B |
Financing Activities | |||||
Share Repurchases | -666.9M | 0 | -166.7M | -1.3B | -187.6M |
Dividends Paid | -116.2M | -110.5M | -100.1M | -100.7M | -99.4M |
Debt Issuance | 75.0M | 740.6M | 0 | 0 | 0 |
Debt Repayment | -150.0M | -30.0M | 0 | 0 | -250.0M |
Financing Cash Flow | -1.3B | 2.6B | 725.3M | -302.5M | 665.2M |
Free Cash Flow | 4.2B | 1.9B | 1.6B | 1.2B | 2.0B |
Net Change in Cash | -1.3B | 1.3B | -5.4B | -3.5B | -237.8M |
Cash Flow Trend
Renaissancere Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
6.13
Forward P/E
6.82
Price to Book
1.13
Price to Sales
0.87
PEG Ratio
6.82
Profitability Ratios
Profit Margin
15.40%
Operating Margin
42.71%
Return on Equity
16.02%
Return on Assets
3.56%
Financial Health
Current Ratio
1.34
Debt to Equity
12.77
Beta
0.29
Per Share Data
EPS (TTM)
$39.16
Book Value per Share
$212.15
Revenue per Share
$263.63
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
rnr | 11.3B | 6.13 | 1.13 | 16.02% | 15.40% | 12.77 |
Everest | 13.8B | 17.13 | 0.92 | 5.52% | 4.55% | 23.89 |
Reinsurance Group of | 11.7B | 15.39 | 0.97 | 7.07% | 3.54% | 47.22 |
Hamilton Insurance | 2.2B | 7.03 | 1.19 | 23.65% | 14.64% | 5.70 |
SiriusPoint | 2.1B | 19.38 | 1.13 | 4.86% | 4.15% | 33.53 |
Greenlight Capital | 452.7M | 11.91 | 0.68 | 5.82% | 5.43% | 9.45 |
Financial data is updated regularly. All figures are in the company's reporting currency.